Outcome for children with relapsed acute myeloid leukemia in the Netherlands following initial treatment between 1980 and 1998: survival after chemotherapy only?

We report the outcome of Dutch pediatric relapsed AML patients and focus on patients treated with chemotherapy alone. Median time from first complete remission to relapse was nine months. Second complete remission (CR2) was achieved in 63%. Overall, only 16% of patients were survivors. When only